📊 Note: Daily ratings and analytics are updated after market close and will be available by 7:00 PM IST.

Details

NameSymbolSector
BAL PHARMA LTD.BALPHARMAPharmaceuticals
Open
68.51
High
70.85
Low
66.35
Close
66.4
Volume
5512
Exchange
nse
Time
23-Jan-2026

Outlook

Score:  

1

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Bal Pharma is  
Long Body
Estimated Stoploss of Bal Pharma is ₹  
70.85
Bal Pharma has a  
Bearishℹ
 pattern. 
Formation of  
Long Body
 candle pattern indicates Bal Pharma has chances of  
Continuationℹ
 of the current trend. 

Trend

Bal Pharma is in  
Downtrendℹ
. 
Price of Bal Pharma is  
Downℹ
 by  

8.98

%. 
Target
Buy @ 

66.35

Sell @ 

75.38

Current @ 

66.4

Volume

The trade volumes of Bal Pharma have become  
Deficientℹ
The volume trend for Bal Pharma is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Bal Pharma is  

Down

 by  

32.81

% 

Valuation

The current market price of Bal Pharma is  
Undervaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 335cr and total assets worth ₹ 335cr, the balance sheet of Bal Pharma is:  
Balancedℹ
. 
Cashflow
Bal Pharma has  
Poorℹ
 cash flow because there is  

Shortage

 of  

₹ 2cr

. It is  
Downℹ
 by  

200

%. 

(*Mar 2025)

48.78% i.e. ₹ 20cr earned in operatingℹ
34.15% i.e. ₹ 14cr spent in investingℹ
17.07% i.e. ₹ 7cr spent in financingℹ
0% in otherℹ
Bal Pharma has  
Sufficientℹ
 cash flow because there is  

Surplus

 of  

₹ 2cr

. It is  
Upℹ
 by  

0

%. 

(*Mar 2024)

53.66% i.e. ₹ 22cr earned in operatingℹ
43.9% i.e. ₹ 18cr spent in investingℹ
2.44% i.e. ₹ 1cr spent in financingℹ
0% in otherℹ
Income
The income of Bal Pharma is  

₹ 75cr

 and  

Loss

 is :  

₹ 0cr

(*Sep 2025)

Bal Pharma Losses increased by:  

0

% and Income is Up by:  

13.64

% 

(*Sep 2025)

The income of Bal Pharma is  

₹ 66cr

 and  

Loss

 is :  

₹ 0cr

(*Jun 2025)

Bal Pharma Losses increased by:  

100

% and Income is Down by:  

19.51

% 

(*Jun 2025)

The income of Bal Pharma is  

₹ 82cr

 and  

Profit

 is :  

₹ 5cr

(*Mar 2025)

Bal Pharma Profit is up by:  

500

% and Income is Up by:  

12.33

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.